These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 95627)

  • 1. Adsorption of thyroid-stimulating antibody (TSAb) of Graves' disease by homologous and heterologous thyroid tissue.
    Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1978 Oct; 47(4):906-8. PubMed ID: 95627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoological specificity of human thyroid-stimulating antibody.
    Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1978 Aug; 47(2):249-54. PubMed ID: 45462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M; Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
    Macchia E; Fenzi GF; Monzani F; Lippi F; Vitti P; Grasso L; Bartalena L; Baschieri L; Pinchera A
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease.
    Zakarija M; Garcia A; McKenzie JM
    J Clin Invest; 1985 Nov; 76(5):1885-91. PubMed ID: 2997295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenylate cyclase activity and the accumulation and release of adenosine 3',5'-monophosphate in normal human thyroid tissue slice preparations: responses to thyrotropin and thyroid-stimulating antibodies.
    Bidey SP; Marshall NJ; Ekins RP
    J Clin Endocrinol Metab; 1981 Aug; 53(2):246-53. PubMed ID: 6114107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
    Ochi Y; Kajita Y; Hachiya T; Hamaoki M
    Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody.
    Zakarija M; McKenzie JM
    Endocrinology; 1980 Dec; 107(6):2051-4. PubMed ID: 6107244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radioiodine on stimulatory activity of Graves' immunoglobulins.
    Atkinson S; McGregor AM; Kendall-Taylor P; Peterson MM; Smith BR
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):537-43. PubMed ID: 6125279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.
    Zakarija M; McKenzie JM; Munro DS
    J Clin Invest; 1983 Oct; 72(4):1352-6. PubMed ID: 6138363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
    Li J; Gao H; Jin SX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
    Zakarija M; McKenzie JM
    Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.